WHIRLPOOL CORP /DE/
WHRInvestment snapshot
Positive
5
BUY / PASS
Neutral / negative
2 / 9
NEUTRAL / FAIL
Median fair value
$49.45
+70.1% vs price
Models with upside
6 / 17
Positive margin of safety
Strongest signal
Models split on WHR at $29.06 — fair values range $11.96–$147.26
Key risk
All 12 investors flag WHR's debt & leverage
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | PASS | FAIL | FAIL | FAIL · Rank #1055 (Top 34.1%) | PASS | PASS | PASS | NEUTRAL | FAIL | BUY | FAIL | NEUTRAL | FAIL | FAIL | FAIL | FAIL | FAIL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||
| Margin of Safety | +63.1% | +48.4% | N/A | +69.0% | N/A | +31.7% | -122.3% | -101.9% | +80.3% | +66.8% | -143.0% | -10.5% | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Annual history · FY 2025 Latest source filing: 2026-10-27 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 Latest source filing: 2026-10-27 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-09-30 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30 Latest source filing: 2026-10-27 Score computed: 2026-11-14 | TTM ended 2026-09-30 Latest source filing: 2026-10-27 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-02-11 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01 Latest source filing: 2026-10-27 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 Latest source filing: 2026-10-27 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-02-11 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 Latest source filing: 2026-10-27 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 · Qualitative assessment Latest source filing: 2026-10-27 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01 Latest source filing: 2026-10-27 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30 Latest source filing: 2026-10-27 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-11 Score computed: 2026-11-14 | TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025 Latest source filing: 2026-10-27 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 Latest source filing: 2026-10-27 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-09-30 Latest source filing: 2026-10-27 Score computed: 2026-11-14 | TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-10-27 Score computed: 2026-11-14 |
Where It Passes
- Valuation models60% pass✓ 6✗ 4▾
Models split on WHR at $29.06 — fair values range $11.96–$147.26
Graham fair value$78.74✓Graham+63.1% margin vs $29.06Buffett fair value$56.34✓Buffett+48.4% margin vs $29.06Greenblatt fair value$93.86✓Greenblatt+69.0% margin vs $29.06Dreman fair value$42.55✓Dreman+31.7% margin vs $29.06Munger fair value$13.07✗Munger-122.3% margin vs $29.06Pabrai fair value$14.39✗Pabrai-101.9% margin vs $29.06Akre fair value$147.26✓Akre+80.3% margin vs $29.06Marks fair value$87.51✓Marks+66.8% margin vs $29.06Ackman fair value$11.96✗Ackman-143.0% margin vs $29.06Templeton fair value$26.30✗Templeton-10.5% margin vs $29.06 - Valuation54% pass✓ 18✗ 10▾
7 of 13 pass — Lynch, Greenblatt, Asness +3 more object
Price / 3-yr avg EPS10.2x✓Graham<= 15xPrice-to-Book Ratio0.6x✓Graham<= 1.5xP/E x P/B6.10✓Graham<= 22.5Basic earnings-growth PEG (dividends excluded)P/E 5.1x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value5.6%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=5.6%, ROC=23.3%✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS5.1x✓Dreman< 12x✓Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)3.5x✓Dreman< 8xPrice / Book Value per Share0.6x✓Dreman< 1.2x✓Templeton< 1.5x✓SchlossP/B <= 0.80x (app cutoff)Valuation ReasonablenessP/E=5.1x, OE Yield=16.4%✓MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=5.1x, FCF Yield=4.2%✓PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=5.1x, P/B=0.6x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value31.7% (IV=$42.55 vs Price=$29.06)✓Marks>= 20% below intrinsic valuePrice / FCF per Share20.1x✓Ackman<= 25Price vs. Trailing Low100% of trailing low ($29.06)✓Templeton<= 120% of trailing low (certified split-adjusted live window)Net income / market capitalization-6.44%; #3975/6340 (top 62.7%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+1.9505; #697/6449 (top 10.8%)✓AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS5.1x✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E-0.27✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per ShareN/A (non-positive TBVPS)✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change-21.1%✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+7.6244; #395/5247 (top 7.5%)✓OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization-4.82%; #2970/4519 (top 65.7%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-33.07%; #4538/6202 (top 73.2%)✗OshaughnessyTop 10% of eligible cross-section
Where It Falls Short
- Debt & Leverage0% pass✗ 15▾
All 12 investors flag WHR's debt & leverage
LT Debt vs Net Current AssetsLT Debt $6.8B vs NCA $724.0M✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 1.84, IC: 1.3x✗BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity1.84✗Lynch< 0.33Cash - Long-term Debt$-5.7B✗LynchPositive preferredLT Debt / Total Assets Change29.19% -> 34.89%✗PiotroskiDecreased YoYCurrent Assets / Current Liabilities1.15✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity1.84✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00xDebt Levels1.84✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=1.3x, D/EBITDA=8.5x✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity1.84✗Ackman<= 1.0Negative debt-to-equity (higher means less debt)-1.8352; #3730/4210 (top 88.6%)✗AsnessTop 30% of eligible cross-section - Efficiency0% pass✓ 1✗ 10▾
No clean pass — all 8 investors flag at least one efficiency criterion
Current Ratio1.15✗Graham>= 2.0ROIC (3-5 yr avg)7.1%✗Buffett> 10%ROIC - WACC-2.9%✗BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)23.3%✗Greenblatt> 25%Current Ratio Change YoY0.72 -> 0.76✓PiotroskiIncreased YoYRevenue / Total Assets Change YoY1.02x -> 0.97x✗PiotroskiImproved YoYCurrent Assets / Current Liabilities1.15✗Dreman> 1.5Return on Invested Capital3.2%✗Munger> 15%ROIC (high and growing)FY2023: ROIC=8.4%; FY2024: ROIC=1.2%; FY2025: ROIC=7.4%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROICN/A (non-positive net income)✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)1/5 years above 12% (latest 7.4%)✗SleepROIC > 12% in a majority of years - Growth13% pass✓ 3✗ 10▾
7 of 8 flag WHR's growth — Graham, Lynch, Dreman +4 more
EPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)P/E 5.1x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR-19.8%✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: -12.3% vs Rev: -6.4%✓LynchInventory growth < Revenue growthEPS Growth Direction✗DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedPositive Net Income Frequency21/24 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth-6.5%✗Ackman>= 5%Positive EPS Growth Frequency3/5 years with positive EPS growth✓AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR-19.8% CAGR over 5 years✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 16.3% -> 15.4%, operating margin 5.2% -> 5.4%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR-4.4%✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR-19.8% over 5 years✗Neff7%-20% annualized - Profitability19% pass✓ 9✗ 26▾
13 of 16 flag WHR's profitability — Graham, Buffett, Lynch +10 more
Positive EPS (10 years)22/25 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthNet Income Positive (10+ years)21/25 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)-1.6%✗Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)5.4% (latest)✓BuffettStable or rising over 10 yearsFree Cash Flow Proxy$267.0M✗BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)P/E 5.1x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR-19.8%✗Lynch15-30% (Fast Grower); > 0% to passROE-3.3%✗Lynch> 15%EBIT / Enterprise Value5.6%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=5.6%, ROC=23.3%✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets1.99%✓PiotroskiROA > 0ROA Change YoY-1.98% -> 1.99% (delta: +3.97%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=2.94%, ROA=1.99%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY15.5% -> 15.4%✗PiotroskiImproved YoYPre-Tax Income / Revenue0.5%✗Dreman>= 8%Net Income / Shareholders' Equity-3.3%✗Dreman> 12%Margin of SafetyP/E=5.1x, P/B=0.6x✓PabraiP/B < 1.5 or P/E < 15Return on Equity6.7% (3-yr avg)✗AkreROE > 20% (3-year avg)Discount to Intrinsic Value31.7% (IV=$42.55 vs Price=$29.06)✓Marks>= 20% below intrinsic valuePositive Net Income Frequency21/24 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue2.9%✗Ackman>= 15%Net Income / Shareholders Equity-3.3%✗Ackman>= 15%5-Year EPS CAGR-19.8% CAGR over 5 years✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend5.2% (2023) -> 5.4% (2025)✓TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 16.3% -> 15.4%, operating margin 5.2% -> 5.4%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingNet income / market capitalization-6.44%; #3975/6340 (top 62.7%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets+11.23%; #2715/3702 (top 73.3%)✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity-3.30%; #3122/5226 (top 59.7%)✗AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0583; #2777/5884 (top 47.2%)✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR-19.8% over 5 years✗Neff7%-20% annualizedPositive Diluted-EPS Years7/10 years positive✓Schloss>= 70% positive over 5-10 observed years (app rule) - Verdicts33% pass✓ 5✗ 10▾
Split decision: 9 FAIL · 4 PASS · 2 NEUTRAL · 1 BUY
Overall verdict✓GrahamPASS (5/9)✗BuffettFAIL (1/9)✗LynchFAIL (1/7)✗GreenblattRank #1055✓PiotroskiPASS (F-Score 5)✓DremanPASS (5/11)✓MungerPASS (2/4)•PabraiNEUTRAL (2/3)✗AkreFAIL (1/6)✓MarksBUY (4/5)✗AckmanFAIL (3/9)•TempletonNEUTRAL (6/8)✗SleepFAIL (2/6)✗AsnessFAIL (Rank #1877/2370 (Top 79.2%))✗NeffFAIL (2/6)✗SchlossFAIL (3/7)✗OshaughnessyFAIL (Rank #438/963 (Top 45.5%)) - Cash Flow50% pass✓ 7✗ 5▾
5 of 10 pass — Buffett, Lynch, Ackman +2 more object
Free Cash Flow Proxy$267.0M✗BuffettPositive and growingFCF Positive and Growing$-92.0M✗LynchPositive and growingOperating Cash Flow$470.0M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=2.94%, ROA=1.99%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)3.5x✓Dreman< 8xP/E or FCF YieldP/E=5.1x, FCF Yield=4.2%✓PabraiP/E < 15 or FCF Yield > 10%FCF Positive16/18 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap-5.7%✗Ackman>= 4%Price / FCF per Share20.1x✓Ackman<= 25Positive Operating Cash Flow frequency24/24 years positive✓SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$-92.0M✗Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization-4.82%; #2970/4519 (top 65.7%)✗OshaughnessyTop 10% of eligible cross-section
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Issued 1.8% of shares last year, 1.8% issued over two.
- Buybacks
- $0
- Dividends
- $300.0M
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | TTM · 2026-09-30 2025-10-01 – 2026-09-30 Sources · derived quarter valuesDerived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, interest expense, operating cash flow, depreciation amortization, capex, dividends paid, buybacks. | Q3 FY 2026 2026-07-01 – 2026-09-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, capex, dividends paid. | Q2 FY 2026 2026-04-01 – 2026-06-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, capex, dividends paid. | Q1 FY 2026 2026-01-01 – 2026-03-31 Sources | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.9Bcurrent | -- | -- | -- | $4.5Best. | $5.8Best. | $5.2Best. | $6.9Best. | $9.8Best. |
| Revenue | $14.6B↓6% | $3.7B↓9% | $3.5B↓7% | $3.3B↓10% | $15.5B↓7% | $16.6B↓15% | $19.5B↓1% | $19.7B↓10% | $22.0B |
| Operating Income | $428.0M↓7% | $4.0M↓98% | $163.0M↓20% | $18.0M↓90% | $838.0M↑486% | $143.0M↓86% | $1.0B↑196% | -$1.1B↓145% | $2.3B |
| Net Income | -$123.0M↑33% | -$237.0M↓425% | $88.0M↑35% | -$82.0M↓215% | $318.0M↑198% | -$323.0M↓167% | $481.0M↑132% | -$1.5B↓185% | $1.8B |
| EPS (Diluted) | -- | $-3.80↓395% | $1.15↓2% | $-1.43↓212% | $5.66↑196% | $-5.87↓167% | $8.72↑132% | $-27.18↓196% | $28.36 |
| Gross Margin | 13.1%↓18% | 12.9%↓13% | 12.6%↓22% | 12.7%↓24% | 15.4%↓1% | 15.5%↓5% | 16.3%↑5% | 15.6%↓22% | 20.1% |
| Operating Margin | 2.9% | 0.1%↓98% | 4.6%↓14% | 0.5%↓89% | 5.4%↑527% | 0.9%↓83% | 5.2%↑197% | -5.4%↓150% | 10.7% |
| ROE | -3.3%↑52% | — | — | — | 11.7%↑197% | -12.0%↓159% | 20.4%↑131% | -65.0%↓277% | 36.8% |
| Total Debt | $6.8B↑6% | $6.8B↑6% | $7.1B↑9% | $6.1B↓8% | $6.2B↓7% | $6.6B↓8% | $7.2B↓5% | $7.6B↑46% | $5.2B |
| Shareholders' Equity | $3.7B↑41% | $3.7B↑41% | $3.9B↑52% | $3.8B↑47% | $2.7B↑2% | $2.7B↑14% | $2.4B↑1% | $2.3B↓52% | $4.8B |
| Current Ratio | 1.15↑34% | 1.15↑34% | 1.15↑36% | 0.88↑22% | 0.76↑6% | 0.72↓20% | 0.89↓17% | 1.08↓5% | 1.14 |
| Debt / Equity | 1.84↓25% | 1.84↓25% | 1.79↓28% | 1.62↓38% | 2.26↓8% | 2.46↓19% | 3.05↓6% | 3.26↑202% | 1.08 |
| Operating Cash Flow | $313.0M↓28% | $121.0M↑267% | -$120.0M↓732% | -$827.0M↓15% | $470.0M↓44% | $835.0M↓9% | $915.0M↓34% | $1.4B↓36% | $2.2B |
| Free Cash Flow | -$92.0M↓248% | $28.0M↑154% | -$214.0M↓240% | -$895.0M↓13% | $81.0M↓79% | $384.0M↑5% | $366.0M↓55% | $820.0M↓50% | $1.7B |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Consumer Goods
WHR vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNILEVER PLCUL | $142.6B | $66.21 | $59.3B | $11.1B | 61.0% | 1.68 | 17.9% | 0.79 | 2/9 | 4/9 | 4/7 | 1/3 | F-Score 8 | 6/11 |
| ECOLAB INC.ECL | $86.7B | $309.27 | $16.1B | $2.1B | 21.2% | 0.84 | 17.0% | 1.08 | 3/9 | 5/9 | 3/7 | 1/3 | F-Score 6 | 5/11 |
| COLGATE PALMOLIVE COCL | $79.2B | $99.67 | $20.4B | $2.1B | 3948.1% | 147.89 | 16.2% | 0.83 | 2/9 | 5/9 | 3/7 | 1/3 | F-Score 5 | 3/11 |
| ESTEE LAUDER COMPANIES INCEL | $40.5B | $111.75 | $14.3B | $1.1B | -29.3% | 1.89 | -5.5% | 1.30 | 2/9 | 4/9 | 2/7 | 0/3 | F-Score 6 | 1/11 |
| CHURCH & DWIGHT CO INC /DE/CHD | $26.7B | $113.00 | $6.2B | $736.8M | 18.4% | 0.55 | 17.4% | 1.07 | 3/9 | 7/9 | 3/7 | 1/3 | F-Score 7 | 4/11 |
| CANON INCCAJPY | $25.2B | $30.28 | — | — | — | — | — | — | 3/9 | 1/9 | 1/7 | 1/3 | F-Score 7 | 5/11 |
| SOMNIGROUP INTERNATIONAL INC.SGI | $14.0B | $60.76 | $7.5B | $384.1M | 12.4% | 1.51 | 10.1% | 0.83 | 1/9 | 5/9 | 2/7 | 1/3 | F-Score 5 | 2/11 |
| INTERPARFUMS INCIPAR | $4.3B | $133.37 | $1.5B | $168.4M | 19.1% | 0.20 | 18.2% | 2.99 | 4/9 | 5/9 | 6/7 | 1/3 | F-Score 5 | 7/11 |